A phase I study of chemo-radiotherapy with plerixafor for newly diagnosed glioblastoma (GB).

被引：7

作者：

Thomas, Reena Parada

Nagpal, Seema

Iv, Michael

Soltys, Scott G.

Corbin, Zachary

Xu, Linda Wei

Recht, Cathy Kahn

Bertrand, Sophie

Jain, Vani

Acevedo, Brenda

Brown, Martin

Recht, Lawrence David

机构：

[1] Stanford Univ Hosp, Stanford, CA 94305 USA

[2] Stanford Canc Ctr, Stanford, CA USA

[3] Stanford Canc Inst, Stanford, CA USA

[4] Stanford Univ, Stanford, CA 94305 USA

[5] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA

[6] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期

关键词：

D O I：

10.1200/JCO.2016.34.15_suppl.2068

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2068

引用

页数：2

共 50 条

[31] An update of phase II results from RTOG 0211: A phase I/II study of gefitinib with radiotherapy in newly diagnosed glioblastoma multiforme
Chakravarti, A.
Berkey, B.
Robins, I.
Guha, A.
Curran, W.
Brachman, D.
Shultz, C.
Mehta, M.
NEURO-ONCOLOGY, 2006, 8 (04) : 439 - 439
[32] A phase II study of alternating chemo-radiotherapy in the treatment of esophageal carcinoma
Sanguineti, O
Nobile, MT
Chiara, S
Barzacchi, MC
Gozza, A
Simoni, C
Forno, GB
Murolo, C
Orsatti, M
Scarpati, D
Vitale, V
Merlano, M
ANNALS OF ONCOLOGY, 1998, 9 : 50 - 50
[33] PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
Kebir, Sied
Pierscianek, Daniela
Proescholdt, Martin
Hau, Peter
Grosu, Anca-Ligia
Krex, Dietmar
Sure, Ulrich
Scheffler, Bjoern
Stuschke, Martin
Glas, Martin
NEURO-ONCOLOGY, 2021, 23 : 68 - 68
[34] PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
Kebir, S.
Pierscianek, D.
Proescholdt, M.
Hau, P.
Grosu, A.
Krex, D.
Sure, U.
Scheffler, B.
Stuschke, M.
Glas, M.
NEURO-ONCOLOGY, 2021, 23 : 50 - 50
[35] PriCoTTF Trial: A phase I/II trial of TTFields prior and concomitant to radiotherapy in newly diagnosed glioblastoma
Kebir, S.
Lazaridis, L.
Schmidt, T.
Oster, C.
Pierscianek, D.
Guberina, N.
Kleinschnitz, C.
Proescholdt, M.
Hau, P.
Grosu, A. -L
Sure, U.
Scheffler, B.
Stuschke, M.
Glas, M.
STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S74 - S74
[36] PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
Kebir, Sied
Lazaridis, Lazaros
Schmidt, Teresa
Oster, Christoph
Pierscianek, Daniela
Guberina, Nika
Kleinschnitz, Christoph
Proescholdt, Martin
Hau, Peter
Grosu, Anca-Ligia
Sure, Ulrich
Scheffler, Bjoern
Stuschke, Martin
Glas, Martin
NEURO-ONCOLOGY, 2020, 22 : 61 - 61
[37] PHASE II STUDY OF BEVACIZUMAB, TEMOZOLOMIDE, AND HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY (HFSRT) FOR NEWLY DIAGNOSED GLIOBLASTOMA
Omuro, Antonio
Beal, Kathryn
Correa, Denise
Chan, Timothy
DeAngelis, Lisa
Gavrilovic, Igor
Nolan, Craig
Hormigo, Adilia
Lassman, Andrew B.
Kaley, Thomas
Mellinghoff, Ingo
Grommes, Christian
Panageas, Kathryn
Reiner, Ann
Barradas, Renata
Abrey, Lauren
Gutin, Philip
NEURO-ONCOLOGY, 2011, 13 : 59 - 60
[38] Patterns of tumor progression in a phase 3 study of bevacizumab (Bv) pies radiotherapy (RI) phis temozolomide (T) for newly diagnosed glioblastoma (GB)
Wick, Wolfgang
Chinot, Olivier L.
Mason, Warren P.
Henriksson, Roger
Saran, Frank
Nishikawa, Ryo
Revil, Cedric
Kerloeguen, Yannick
Cloughesy, Timothy Francis
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[39] Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations
Chinot, OL
Barrie, M
Frauger, E
Dufour, H
Figarella-Branger, D
Palmari, J
Braguer, D
Hoang-Xuan, K
Moktari, K
Peragut, JCC
Martin, PMM
Grisoli, F
CANCER, 2004, 100 (10) : 2208 - 2214
[40] Phase II - Study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations
Alliot, C
CANCER, 2004, 101 (12) : 2897 - 2898

← 1 2 3 4 5 →